(OA23) Do Vaginal Recurrence Rates Differ Among Common Adjuvant Vaginal Brachytherapy Regimens in Early-Stage Endometrial Cancer?

Bryan J. Ager,Samual Francis,Olivia A. Do,Y Huang,Andrew P. Soisson,Mark K. Dodson,Theresa L. Werner,Jonathan D. Grant,David K. Gaffney

International Journal of Radiation Oncology*Biology*Physics（2018）

Cited 0|Views18

No score

Abstract

Adjuvant vaginal brachytherapy after hysterectomy has been shown to reduce the risk of vaginal recurrence for patients with early-stage endometrial cancer. We sought to retrospectively examine clinical outcomes at our institution for three commonly used vaginal cylinder HDR brachytherapy regimens.

Translated text

Key words

Endometrial Carcinoma

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined